{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:45:52Z","timestamp":1774464352362,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.neuropharm.2011.12.034","type":"journal-article","created":{"date-parts":[[2012,1,11]],"date-time":"2012-01-11T14:56:56Z","timestamp":1326293816000},"page":"2010-2017","source":"Crossref","is-referenced-by-count":30,"title":["Memantine partly rescues behavioral and cognitive deficits in an animal model of neurodegeneration"],"prefix":"10.1016","volume":"62","author":[{"given":"Yuliya","family":"Borre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmeralda","family":"Bosman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Lemstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen G.","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berend","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald S.","family":"Oosting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neuropharm.2011.12.034_bib1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1023\/B:BIRY.0000018948.04559.ab","article-title":"Increased level of beta-amyloid in the brain of bulbectomized mice","volume":"69","author":"Aleksandrova","year":"2004","journal-title":"Biochemistry (Mosc)."},{"key":"10.1016\/j.neuropharm.2011.12.034_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0014-2999(99)00927-9","article-title":"Effects of NMDA receptor antagonists on cocaine-conditioned motor activity in rats","volume":"3","author":"Bespalov","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.12.034_bib3","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.biopsych.2006.08.032","article-title":"Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats","volume":"61","author":"Breuer","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2011.12.034_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejphar.2009.06.029","article-title":"Antidepressant effects of pramipexole, a dopamine D3\/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats","volume":"616","author":"Breuer","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.12.034_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1054-3589(08)60950-3","article-title":"The pharmacology of (-)-nicotine and novel cholinergic channel modulators","volume":"37","author":"Brioni","year":"1997","journal-title":"Adv. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2011.12.034_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hipo.20720","article-title":"Interhippocampal transfer in passive avoidance task modifies metabolic activity in limbic structures","volume":"21","author":"Cimadevilla","year":"2011","journal-title":"Hippocampus"},{"issue":"15","key":"10.1016\/j.neuropharm.2011.12.034_bib7","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1523\/JNEUROSCI.4883-05.2006","article-title":"Low doses of memantine disrupt memory in adult rats","volume":"26","author":"Creeley","year":"2006","journal-title":"J.\u00a0Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2011.12.034_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/aps.2009.24","article-title":"Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases","volume":"30","author":"Dong","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2011.12.034_bib9","article-title":"Simvastatin improves learning and memory in control but not in olfactory bulbectomized rats","volume":"8","author":"Douma","year":"2011","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2011.12.034_bib10","first-page":"81","article-title":"Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial","volume":"42","author":"Feusner","year":"2009","journal-title":"Psychopharm. Bull."},{"issue":"5","key":"10.1016\/j.neuropharm.2011.12.034_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/gps.1341","article-title":"Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomized, controlled studies","volume":"20","author":"Gauthier","year":"2005","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.12.034_bib12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.60.5.753","article-title":"Depression as a risk factor for Alzheimer disease: the MIRAGE Study","volume":"60","author":"Green","year":"2003","journal-title":"Arch. Neurol."},{"issue":"7","key":"10.1016\/j.neuropharm.2011.12.034_bib13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nrd3115","article-title":"Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives","volume":"9","author":"Hampel","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.neuropharm.2011.12.034_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainresrev.2009.05.005","article-title":"Emerging role of glutamate in the pathophysiology of major depressive disorder","volume":"61","author":"Hashimoto","year":"2009","journal-title":"Brain Res. Rev."},{"issue":"2","key":"10.1016\/j.neuropharm.2011.12.034_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3940(00)01152-6","article-title":"Striatal glutamate release during novelty exposure-induced hyperactivity in olfactory bulbectomized rats","volume":"287","author":"Ho","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2011.12.034_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0166-4328(02)00183-3","article-title":"Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy","volume":"138","author":"Hozumi","year":"2003","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2011.12.034_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.expneurol.2006.09.008","article-title":"Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy","volume":"204","author":"Jarosik","year":"2007","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuropharm.2011.12.034_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.brainres.2006.02.081","article-title":"Alzheimer's disease drugs promotes neurogenesis","volume":"1085","author":"Jin","year":"2006","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2011.12.034_bib19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.psyneuen.2010.03.004","article-title":"Impact of glucocorticoids on brain function: relevance for mood disorder","volume":"36","author":"Joels","year":"2011","journal-title":"Psychoneuroendocrionlogy"},{"issue":"4\u20135","key":"10.1016\/j.neuropharm.2011.12.034_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neuropharm.2010.04.008","article-title":"Fluoxetine protects against amyloid-beta toxicity, in part via daf-16 mediated cell signaling pathway, in Caenorhabditis elegans","volume":"59","author":"Keowkase","year":"2010","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2011.12.034_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0006-8993(96)00213-2","article-title":"Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: effects on spatial working memory in rats","volume":"725","author":"Kim","year":"1996","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2011.12.034_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1037\/h0027657","article-title":"Exploratory behavior and spontaneous alternation in blind and anosmic rats","volume":"68","author":"Klein","year":"1969","journal-title":"J.\u00a0Comp. Physiol. Psychol."},{"key":"10.1016\/j.neuropharm.2011.12.034_bib23","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1073\/pnas.0910658107","article-title":"Nuclear factor-kappaB is a critical of stress-impaired neurogenesis and depressive behavior","volume":"107","author":"Koo","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2011.12.034_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0006-3223(03)00543-2","article-title":"Depression in Alzheimer's disease: heterogeneity and related issues","volume":"54","author":"Lee","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2011.12.034_bib25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrd1958","article-title":"Paradigm shift in neuroprotection by NMDA receptor blockade memantine and beyond","volume":"5","author":"Lipton","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.neuropharm.2011.12.034_bib26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/138945007780618472","article-title":"Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation","volume":"8","author":"Lipton","year":"2007","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.neuropharm.2011.12.034_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.yebeh.2008.08.013","article-title":"Different effects of two N-methyl-D-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats","volume":"14","author":"Mares","year":"2009","journal-title":"Epilepsy Behav."},{"issue":"3","key":"10.1016\/j.neuropharm.2011.12.034_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/mcne.2001.1027","article-title":"The neuroprotective agent memantine induces brain-derived neurotropic factor and trkB receptor expression in rat brain","volume":"18","author":"Marvanov\u00e1","year":"2001","journal-title":"Mol. Cell Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2011.12.034_bib29","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/sj.npp.1301615","article-title":"Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine","volume":"33","author":"Meisner","year":"2008","journal-title":"Neurospsychopharmacology"},{"issue":"7","key":"10.1016\/j.neuropharm.2011.12.034_bib30","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.neuropharm.2008.02.014","article-title":"Cognition-enhancing and anxiolytic effects of memantine","volume":"54","author":"Minkeviciene","year":"2008","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2011.12.034_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1471-4159.2006.03710.x","article-title":"Decreased calcium\/calmodulin-dependent protein kinase II and protein kinase C activities mediate impairment of hippocampal long-term potentiation in the olfactory bulbectomized mice","volume":"97","author":"Moriguchi","year":"2006","journal-title":"J.\u00a0Neurochem."},{"issue":"4","key":"10.1016\/j.neuropharm.2011.12.034_bib32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000121334","article-title":"Is antidepressant treatment associated with reduced cognitive decline in Alzheimer's disease?","volume":"25","author":"Mossello","year":"2008","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"5579","key":"10.1016\/j.neuropharm.2011.12.034_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.1071795","article-title":"Requirement for hippocampal CA3 NMDA receptors in associative memory recall","volume":"297","author":"Nakazawa","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neuropharm.2011.12.034_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/syn.10006","article-title":"Altered dendritic spine density in animal models of depression and in response to antidepressant treatment","volume":"42","author":"Norrholm","year":"2001","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.neuropharm.2011.12.034_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0301-0511(81)90021-1","article-title":"Impairments of search behaviour in rats after haloperidol treatment, hippocampal or neocortical damage suggest a mesocorticolimbic role in cognition","volume":"12","author":"Oades","year":"1981","journal-title":"Biol. Psychol."},{"issue":"3","key":"10.1016\/j.neuropharm.2011.12.034_bib48","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0091-6773(79)90184-6","article-title":"The development of food search behavior by rats: the effects of hippocampal damage and haloperidol","volume":"24","author":"Oades","year":"1978","journal-title":"Behav. Biol."},{"issue":"5","key":"10.1016\/j.neuropharm.2011.12.034_bib36","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1248\/bpb.32.850","article-title":"Influence of memantine on brain monoaminergic neurotransmission parameters in mice: neurochemical and behavioral study","volume":"32","author":"Onogi","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuropharm.2011.12.034_bib37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1177\/0269881106071335","article-title":"The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model","volume":"6","author":"Ostrovskaya","year":"2007","journal-title":"J.\u00a0Psychopharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2011.12.034_bib38","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","article-title":"Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system\u2013too little activation is bad, too much is even worse","volume":"53","author":"Parsons","year":"2007","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.neuropharm.2011.12.034_bib39","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/01.JGP.0000224350.82719.83","article-title":"Memantine treatment in mild to moderate Alzheimer disease: a 24-weekn randomized, controlled trial","volume":"14","author":"Peskind","year":"2006","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2011.12.034_bib40","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.neuroscience.2007.03.018","article-title":"Memantine reduces oxidative damage and enhances long-term recognition memory in aged rats","volume":"146","author":"Pieta Dias","year":"2007","journal-title":"Neuroscience"},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2011.12.034_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.12.034_bib42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neuroscience.2011.03.026","article-title":"Possible antidepressant effects and mechanisms of memantine in behaviors and synaptic plasticity of a depression rat model","volume":"182","author":"Quan","year":"2011","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.neuropharm.2011.12.034_bib43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.brainresbull.2009.11.013","article-title":"Neurochemical and behavioural effects of acute and chronic memantine administration in rats: further support for NMDA as a new pharmacological target for the treatment of depression?","volume":"81","author":"R\u00e9us","year":"2010","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.neuropharm.2011.12.034_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/syn.1105","article-title":"Effects of bilateral olfactory bulbectomy on N-methyl-D-aspartate receptor function: autoradiographic and behavioral studies in the rat","volume":"42","author":"Robichaud","year":"2001","journal-title":"Synapse"},{"issue":"8","key":"10.1016\/j.neuropharm.2011.12.034_bib45","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0028-3908(02)00055-2","article-title":"Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats","volume":"42","author":"Rog\u00f3z","year":"2002","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2011.12.034_bib46","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.neuroscience.2006.08.017","article-title":"Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat","volume":"142","author":"Rosi","year":"2006","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.neuropharm.2011.12.034_bib47","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1073\/pnas.0611718104","article-title":"Paradoxical influence of hippocampal neurogenesis on working memory","volume":"104","author":"Saxe","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.neuropharm.2011.12.034_bib49","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3233\/JAD-2011-101929","article-title":"Sustained effects of once-daily memantine treatment on cognition and functional communication skills in patients with moderate to severe Alzheimer's disease: results of a 16-week open-label trial","volume":"25","author":"Schulz","year":"2011","journal-title":"J.\u00a0Alzheimer's Dis."},{"issue":"2","key":"10.1016\/j.neuropharm.2011.12.034_bib50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/syn.20472","article-title":"Memantine agonist action at dopamine D2High receptors","volume":"62","author":"Seeman","year":"2008","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.neuropharm.2011.12.034_bib51","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.brainresbull.2005.12.001","article-title":"Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study","volume":"69","author":"Shearman","year":"2006","journal-title":"Brain Res. Bull."},{"issue":"5","key":"10.1016\/j.neuropharm.2011.12.034_bib52","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.brainresbull.2008.01.020","article-title":"Olfactory bulbectomy reduces cerebral glucose utilization: 2-(14C)deosyglucose autoradiographic study","volume":"76","author":"Skelin","year":"2008","journal-title":"Brain Res. Bull."},{"issue":"5","key":"10.1016\/j.neuropharm.2011.12.034_bib53","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.brainresbull.2005.09.005","article-title":"Cholinergic receptor subtypes in the olfactory bulbectomy model of depression","volume":"68","author":"Slotkin","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2011.12.034_bib54","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neubiorev.2005.03.010","article-title":"The olfactory bulbectomised rat as a model of depression","volume":"29","author":"Song","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2011.12.034_bib55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1601-183X.2007.00379.x","article-title":"Changes in adult neurogenesis in neurodegenerative diseases: cause or consequence?","volume":"7","author":"Thompson","year":"2008","journal-title":"Genes Brain Behav."},{"issue":"2","key":"10.1016\/j.neuropharm.2011.12.034_bib56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-4328(89)80081-6","article-title":"Selective fimbria lesions impair acquisition of working and reference memory of rats in a complex spatial discrimination task","volume":"32","author":"van der Staay","year":"1989","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2011.12.034_bib57","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1476-5381.1977.tb07530.x","article-title":"Olfactory bulb ablation in the rat: behavioural changes and their reversal by antidepressant drugs","volume":"60","author":"Van Riezen","year":"1977","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2011.12.034_bib58","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neulet.2010.01.075","article-title":"The differential effects of depression on evoked and spontaneous pain behaviors in olfactory bulbectomized rats","volume":"472","author":"Wang","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"Suppl. 3","key":"10.1016\/j.neuropharm.2011.12.034_bib59","first-page":"3","article-title":"Neuropathologic changes in Alzheimer's disease: potential targets for treatment","volume":"67","author":"Wenk","year":"2006","journal-title":"J.\u00a0Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.neuropharm.2011.12.034_bib60","first-page":"517","article-title":"Effects of anxiolytic drugs on some behavioral consequences in olfactory bulbectomized rats","volume":"53","author":"Wiero\u0144ska","year":"2001","journal-title":"Pol. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2011.12.034_bib61","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0006-8993(00)02619-6","article-title":"An in-vivo magnetic resonance imaging study of the olfactory bulbectomized rat model of depression","volume":"879","author":"Wrynn","year":"2000","journal-title":"Brain Res."},{"issue":"10","key":"10.1016\/j.neuropharm.2011.12.034_bib62","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/npp.2009.64","article-title":"Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by\u00a0preventing microglial activation","volume":"34","author":"Wu","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"33","key":"10.1016\/j.neuropharm.2011.12.034_bib63","doi-asserted-by":"crossref","first-page":"11246","DOI":"10.1523\/JNEUROSCI.2488-10.2010","article-title":"Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses","volume":"30","author":"Xia","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.12.034_bib64","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1248\/yakushi.130.717","article-title":"Donepezil-induced neuroprotection of acetylcholinergic neurons in olfactory bulbectomized mice","volume":"130","author":"Yamamoto","year":"2010","journal-title":"Yakugaku Zasshi"},{"issue":"6","key":"10.1016\/j.neuropharm.2011.12.034_bib65","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.pnpbp.2008.01.008","article-title":"A\u00a0systematic review of off-label uses of memantine for psychiatric disorders","volume":"32","author":"Zdanys","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081200010X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081200010X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T06:30:05Z","timestamp":1561185005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081200010X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":65,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S002839081200010X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.12.034","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}